Posts by: Inês Martins PhD

Inês Martins PhD

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.

October 28, 2016

First Review of ESMO’s Magnitude of Clinical Benefit Scale Offers a Thumbs-Up

News

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a valuable tool to measure the importance of clinically meaningful benefits that can be expected from a new ... Read more

October 26, 2016

Onion Compound May Boost Chemotherapy Effects in Ovarian Cancer, Study Finds

News

A natural compound isolated from onions is able to reduce the progression of ovarian cancer by interfering with the myeloid cells found in the tumor microenvironment, a new study published ... Read more

October 24, 2016

Financial Difficulties Linked to Worse Patient Outcomes in Ovarian, Other Cancers

News

Cancer patients who have financial difficulties have significantly worse quality of life during treatment and may be at higher risk of death, according to the results of a pooled analysis ... Read more

October 21, 2016

Targeting Cancer Stem Cells May Lower Relapse Rates, Early Research Suggests

News

Histone deacetylase (HDAC) inhibitors, which prevent epigenetic modifications in the DNA, may be able to eliminate cancer stem cells (CSCs) in ovarian and breast cancers, making relapses less likely after standard-of-care treatments, researchers ... Read more

October 19, 2016October 19, 2016

Newk’s Cares Raises Over $500,000 in 3 Years for Ovarian Cancer Research

News

Newk’s Cares, the ovarian cancer awareness movement launched by the fast-casual Newk’s Eatery, has reached a fundraising milestone of more than $500,000 in three years. Earlier this year, Newk’s Eatery rallied its restaurants to ... Read more

October 17, 2016

Genetic Signature of Aggressive Ovarian, Endometrial Cancers Unraveled at Yale

News

Carcinosarcomas are rare, highly aggressive tumors associated with very poor outcomes. Recently, researchers at Yale University School of Medicine shed light on the genetic signature of uterine and ovarian carcinosarcomas, which could influence the development ... Read more

October 14, 2016October 14, 2016

Patients with Advanced Ovarian Cancer Seen to Benefit from Oral Therapy in Phase 2 Trial

News

Ovarian cancer patients who are refractory to platinum-based chemotherapy may significantly benefit from the investigative treatment selinexor, according to the results of a Phase 2 clinical trial recently presented at the European ... Read more

October 12, 2016October 31, 2016

Niraparib Maintenance Treatment Significantly Increased Outcomes for Ovarian Cancer Patients

News

Ovarian cancer patients with recurrent, platinum-sensitive disease may benefit greatly from niraparib maintenance treatment, according to data from a Phase 3 trial in which niraparib significantly prolonged patients’ progression-free survival compared ... Read more

October 10, 2016

Increased Cell Membrane Fluidity May Improve Sensitivity to Ovarian Cancer Therapy

News

Cell membrane fluidity may determine ovarian cancer response to the anti-rheumatic drug Ridaura (auranofin) currently in trials for epithelial ovarian cancer, researchers found. The study, “Linking genotoxicity and cytotoxicity with ... Read more

October 7, 2016

Tina’s Wish Benefit Raises $1.4M to Support Ovarian Cancer Early Detection Research

News

In the ninth year of raising funds for ovarian cancer (OC), the annual Tina’s Wish benefit gathered more than 700 supporters to raise $1.4 million for early detection research. The event took ... Read more